Equity Details
Price & Market Data
Price: $0.0₅1
Daily Change: -$0.0₃199 / 19,900%
Daily Range: $0.0₅1 - $0.0₅1
Market Cap: $5,235
Daily Volume: 1,000
Performance Metrics
1 Week: 100.0%
1 Month: 19,900%
3 Months: 100.0%
6 Months: 19,900%
1 Year: 100.0%
YTD: 100.0%
About Anthera Pharmaceuticals, Inc. (ANTH)
Track Anthera Pharmaceuticals, Inc. (ANTH)'s latest movements. Priced at 0.0₅1, the stock has a daily change of -$0.0₃199 / 19,900%. Its market cap stands at 5,235. Gain insights from its 1-year performance (100.0%) and YTD results.
Details
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.